FindTrial
Sign In

To establish whether platelet morphology or functions are altered in patients of Retinal Vein Occlusion

Estimation of Generation of Prothrombotic Phenotype in cases of Retinal Vein Occlusion - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071831
Enrollment
55
Registered
2024-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H348- Other retinal vascular occlusions

Interventions

Control Intervention1: Blood samples of Healthy subjects: Patients of Retinal Vein Occlusion compared with Healthy subjects Control Intervention2: Flowcytometry: Flowcytmetry to assess platelets- neut

Sponsors

IMS BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases of Retinal Vein Occlusion attending the outpatient department of RIO, IMS, BHU . Cases giving written consent to participate in the study.

Exclusion criteria

Exclusion criteria: Acute inflammatory state Patients on anti platelet and anti-coagulant drugs Patients with glaucoma or any optic nerve disorder Patients suffering from major systemic diseases like diabetes mellitus, cardiovascular diseases, anemia, cancer Pregnant and lactating women Patients with other ocular disorders

Design outcomes

Secondary

MeasureTime frame
1.Best corrected visual acuity 2.Slit Lamp Biomicroscopy 3.Oct maculaTimepoint: DAY 0 WEEK 1 WEEK 12—

Primary

MeasureTime frame
Thromboelastography Flowcytometry for assessing platelet neutrophil aggregates circulation OCT maculaTimepoint: Day 0 to Day 7—

Countries

India

Contacts

Public ContactDr Dipti

Banaras Hindu University

dipti321bobby@gmail.com7631723764

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026